Cavitation Technologies, Inc. (CVAT)
OTCMKTS · Delayed Price · Currency is USD
0.0320
+0.0017 (5.61%)
At close: Nov 3, 2026
Cavitation Technologies Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| - | 0 | 0.2 | 1.36 | 0.43 | 1.67 | |
Revenue Growth | - | -98.52% | -85.11% | 214.78% | -73.99% | 198.39% |
Cost of Revenue | - | - | 0.04 | 0.16 | 0.12 | 0.04 |
Gross Profit | - | 0 | 0.17 | 1.21 | 0.31 | 1.62 |
Selling, General & Admin | 1.3 | 1.38 | 1.06 | 0.71 | 1.2 | 1.73 |
Research & Development | 0 | 0.01 | 0.1 | 0.06 | 0 | 0.02 |
Operating Expenses | 1.3 | 1.39 | 1.15 | 0.77 | 1.2 | 1.75 |
Operating Income | -1.3 | -1.39 | -0.99 | 0.44 | -0.89 | -0.12 |
Interest Expense | -0.07 | -0.04 | -0.01 | - | -0.01 | -0.01 |
Interest & Investment Income | - | - | - | 0 | - | - |
Earnings From Equity Investments | - | - | - | - | -1.15 | -0.05 |
Other Non Operating Income (Expenses) | 0.02 | 0.02 | - | - | - | - |
EBT Excluding Unusual Items | -1.35 | -1.4 | -0.99 | 0.44 | -2.04 | -0.17 |
Gain (Loss) on Sale of Assets | - | - | 0.88 | - | - | - |
Asset Writedown | - | - | - | - | - | -0.18 |
Other Unusual Items | - | - | - | - | - | -0.27 |
Pretax Income | -1.35 | -1.4 | -0.11 | 0.44 | -2.04 | -0.62 |
Net Income | -1.35 | -1.4 | -0.11 | 0.44 | -2.04 | -0.62 |
Net Income to Common | -1.35 | -1.4 | -0.11 | 0.44 | -2.04 | -0.62 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 311 | 303 | 286 | 284 | 282 | 249 |
Shares Outstanding (Diluted) | 311 | 303 | 286 | 284 | 282 | 249 |
Shares Change | 8.23% | 6.06% | 0.60% | 0.92% | 13.25% | 26.12% |
EPS (Basic) | -0.00 | -0.00 | -0.00 | 0.00 | -0.01 | -0.00 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | 0.00 | -0.01 | -0.00 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -0.66 | -0.76 | -0.81 | 0.17 | -0.42 | -0.48 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 | -0.00 |
Gross Margin | - | 100.00% | 81.28% | 88.55% | 72.06% | 97.54% |
Operating Margin | - | -46266.67% | -486.21% | 32.14% | -204.62% | -7.27% |
Profit Margin | - | -46800.00% | -55.66% | 32.21% | -471.13% | -37.18% |
Free Cash Flow Margin | - | -25166.67% | -397.04% | 12.62% | -97.69% | -29.07% |
EBITDA | - | - | -0.99 | 0.44 | -0.88 | -0.1 |
EBITDA Margin | - | - | - | 32.21% | -203.93% | -5.95% |
D&A For EBITDA | - | - | 0 | 0 | 0 | 0.02 |
EBIT | -1.3 | -1.39 | -0.99 | 0.44 | -0.89 | -0.12 |
EBIT Margin | - | - | - | 32.14% | -204.62% | -7.27% |
Revenue as Reported | - | - | - | 1.36 | 0.43 | - |